Releases

Current Releases

Resverlogix Completes Patient Recruitment for ASSERT Trial Arthur J. Higgins, CEO of Bayer HealthCare, Appointed to Resverlogix Board of Directors Resverlogix Announces the Closing of an Additional $8 Million Financing view complete archive

02/09/10 22:11 ET Quotes Delayed 20 minutes.